Virtus ETF Advisers LLC Oyster Point Pharma, Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$16.25 - $21.51 $243,668 - $322,542	-14,995 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$17.92 - $25.86 $4,766 - $6,878	266 Added 1.81%	14,995 $274,000
Q4 2020 Feb 12, 2021	BUY	$18.13 - $25.18 $72,828 - $101,148	4,017 Added 37.5%	14,729 $277,000
Q3 2020 Nov 13, 2020	SELL	$17.83 - $29.12 $26,317 - $42,981	-1,476 Reduced 12.11%	10,712 $226,000
Q2 2020 Aug 05, 2020	BUY	$27.86 - $35.93 $339,557 - $437,914	12,188 New	12,188 $352,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.